Literature DB >> 25727926

Incidence of haemoglobinopathies in Sicily: the impact of screening and prenatal diagnosis.

A Giambona1, G Damiani2, M Vinciguerra1, C Jakil2, M Cannata1, F Cassarà1, F Picciotto2, G Schillaci2, V Cigna2, D Renda1, F Leto1, C Passarello1, A Maggio1.   

Abstract

BACKGROUND: Haemoglobinopathies are a major public health problem in Sicily: it was estimated a frequency of 1/245 couples are at risk of haemoglobinopathies. This paper reviews legislative actions, prevention activities, carrier screening, genetic counselling, foetal sampling and laboratory methodology analysis evolution reporting the results of 30 years of prevention actions to assess the efficiency of our preventative programme in the control of haemoglobinopathies in Sicily.
METHODS: This programme consisted principally of five phases: legislative actions, public awareness campaign, carrier screening, genetic counselling and prenatal diagnosis.
RESULTS: These programmes have been very effective, which we can see from a greater public awareness of thalassaemia and its prevention in the target population furthermore by a marked decline in the incidence of thalassaemia major and sickle cell anaemia from 1 in 245 live births in the absence of prevention to 1 in 2000, with a reduction in about 85%. The residual cases were because of a conscious choice by expecting parents in relation to improved life expectancy as well as improved quality of life of the affected patients.
CONCLUSION: The study suggests that public health authorities should act and invest in a similar programme for prevention of thalassaemia, as well as in relation to the increased survival of patients and the consequent organ complications.
© 2015 John Wiley & Sons Ltd.

Entities:  

Mesh:

Year:  2015        PMID: 25727926     DOI: 10.1111/ijcp.12628

Source DB:  PubMed          Journal:  Int J Clin Pract        ISSN: 1368-5031            Impact factor:   2.503


  4 in total

1.  Celomic Fluid: Laboratory Workflow for Prenatal Diagnosis of Monogenic Diseases.

Authors:  Antonino Giambona; Margherita Vinciguerra; Filippo Leto; Filippo Cassarà; Viviana Tartaglia; Valentina Cigna; Emanuela Orlandi; Francesco Picciotto; Nourah H Al Qahtani; Eman S Alsulmi; Noor B Almandil; Sayed AbdulAzeez; J Francis Borgio; Aurelio Maggio
Journal:  Mol Diagn Ther       Date:  2022-02-17       Impact factor: 4.074

Review 2.  Changing patterns in the epidemiology of β-thalassemia.

Authors:  Antonis Kattamis; Gian Luca Forni; Yesim Aydinok; Vip Viprakasit
Journal:  Eur J Haematol       Date:  2020-09-21       Impact factor: 2.997

3.  Transfusional Approach in Multi-Ethnic Sickle Cell Patients: Real-World Practice Data From a Multicenter Survey in Italy.

Authors:  Giovanna Graziadei; Lucia De Franceschi; Laura Sainati; Donatella Venturelli; Nicoletta Masera; Piero Bonomo; Aurora Vassanelli; Maddalena Casale; Gianluca Lodi; Vincenzo Voi; Paolo Rigano; Valeria Maria Pinto; Alessandra Quota; Lucia D Notarangelo; Giovanna Russo; Massimo Allò; Rosamaria Rosso; Domenico D'Ascola; Elena Facchini; Silvia Macchi; Francesco Arcioni; Federico Bonetti; Enza Rossi; Antonella Sau; Saveria Campisi; Gloria Colarusso; Fiorina Giona; Roberto Lisi; Paola Giordano; Gianluca Boscarol; Aldo Filosa; Sarah Marktel; Paola Maroni; Mauro Murgia; Raffaella Origa; Filomena Longo; Marta Bortolotti; Raffaella Colombatti; Rosario Di Maggio; Raffaella Mariani; Alberto Piperno; Paola Corti; Carmelo Fidone; Giovanni Palazzi; Luca Badalamenti; Barbara Gianesin; Frédéric B Piel; Gian Luca Forni
Journal:  Front Med (Lausanne)       Date:  2022-03-16

Review 4.  Sickle cell disease: a review for the internist.

Authors:  Valeria Maria Pinto; Manuela Balocco; Sabrina Quintino; Gian Luca Forni
Journal:  Intern Emerg Med       Date:  2019-08-05       Impact factor: 5.472

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.